# RITHIM BIOLOGICS, INC.: Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | RITHIM BIOLOGICS, INC. |
| Location | WOODBINE, MD |
| Project | Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia |
| Project number | 5R44HL172541-03 |
| Mechanism | R44 |
| Institute | National Heart Lung and Blood Institute |
| Award | $768,857 |
| Awarded | 2026-09-14 |
| Project period | 2024-08-15 to 2027-07-31 |
| UEI | R8S7GFCEVKB3 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11411411). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.